Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/115594
Title: Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants
Authors: Prandoni, Paolo
Milan, Marta 
Sarolo, Lucia 
Zanon, Ezio 
Bilora, Franca 
Keywords: Anticoagulants;Blood coagulation;Fibrin fragment D;Pulmonary embolism;Venous thromboembolism;Venous thrombosis
Keywords Plus: DEEP-VEIN-THROMBOSIS;VITAMIN-K ANTAGONISTS;INTENSITY WARFARIN THERAPY;D-DIMER LEVELS;ORAL ANTICOAGULANTS;PULMONARY-EMBOLISM;LONG-TERM;1ST EPISODE;POSTTHROMBOTIC SYNDROME;RESIDUAL THROMBOSIS
Mesh headings: Anticoagulants;Pulmonary Embolism;Venous Thromboembolism;Venous Thrombosis
Secondary Mesh headings: Blood Coagulation;Drug Administration Schedule;Fibrin Fibrinogen Degradation Products;Hemorrhage;Humans;Randomized Controlled Trials as Topic;Risk Assessment;Risk Factors
Issue Date: Oct-2017
Publisher: EDIZIONI MINERVA MEDICA
Journal: International angiology : a journal of the International Union of Angiology 
Abstract: 
Once anticoagulation is stopped, the risk of recurrent venous thromboembolism (VTE) over years approaches 50% of all patients with a first episode of unprovoked VTE. The persistence of residual vein thrombosis at ultrasound assessment has consistently been shown to increase the risk, as do persistently high values of D-dimer. Although the latest international guidelines suggest indefinite anticoagulation for most patients with the first episode of unprovoked VTE, strategies that incorporate the assessment of residual vein thrombosis and D-dimer have the potential to identify a substantial proportion of subjects in whom anticoagulation can be safely discontinued. For those patients in whom anticoagulation cannot be discontinued, new opportunities are offered by the availability of low-dose anti-Xa compounds, which have been found to possess an extremely favourable benefit/risk profile.
URI: http://hdl.handle.net/20.500.12857/115594
ISSN: 03929590
DOI: 10.23736/S0392-9590.16.03785-8
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

1
Last Week
0
Last month
checked on Aug 7, 2021

SCOPUSTM   
Citations 20

1
checked on Sep 1, 2020

WEB OF SCIENCETM
Citations

1
checked on Nov 26, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.